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Abstract 
      Schimke immune-osseous dysplasia (SIOD) is a rare autosomal recessive disorder presented with 
specific facial features, skeletal dysplasia, steroid resistance nephrotic syndrome (SRNS) and cellular 
immune insufficiency. This is a SIOD case reported from Iran. He was 5 years old boy when 
evaluated for proteinuria and short stature. In appearance, we detected hyperpigmented macules, 
kyphoscoliosis, and warty lesions. He developed progressive renal failure and steroid resistant 
nephrotic syndrome, so kidney biopsy was performed and revealed focal and segmental 
glomerulosclerosis. He didn’t respond to prednisolone and Calcineurin inhibitors. He had recurrent 
lymphopenia with low CD4/CD8 ratio.  
However lymphopenia respond to granulocyte colony-stimulating factor (G-CSF), he died with 
pneumonia and sepsis. Nephrotic syndrome due to focal segmental glomerulosclerosis may be 
accompanied by syndromes. In Qazvin province, we see autosomal recessive disorders more, because 
of consanguineous marriages. To the best of our knowledge, this is the fourth case of SIOD to be 
reported from Iran.  
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1- INTRODUCTION 
     Schimke immune-osseous dysplasia 
(SIOD) characterized by spondylo-
epiphyseal dysplasia (SED), steroid-
resistant nephrotic syndrome due to focal 
segmental glomerulosclerosis and T-cell 
immunodeficiency (1). The other features 
are hyperpigmented macules, recurrent 
infections, cerebral ischemia, intellectual 
delay, hypothyroidism, testicular 
hypoplasia. Mutations were detected in 
SMARCAL1 gene at chromosome 2q35. 
This gene encodes a member of an SNF2 
subfamily of proteins that mediate DNA-
nucleosome restructuring during gene 
regulation and DNA replication, 
recombination, methylation and gene 
repair. 
2- CASE REPORT 
     We describe an Iranian patient with 
immuno-osseous dysplasia. He was an 
eleven-year- old boy. He was second son 
of healthy consanguineous parents. His 
parents were cousins. His parents and 15 
years old brother were healthy and have 
normal stature (his mother was 36 years 
old and 171 cm height, his father was 41 
and 182 cm height). His mother had a 
history of still birth son. He was product of 
caesarean section at 37 weeks of gestation 
with birth weight of 1,700 gr, birth length 
43 cm, and head circumference 32 cm. He 
was assessed for short stature at 5 years 
old, and steroid-resistant nephrotic 
syndrome was detected. Kidney biopsy 
revealed focal segmental 
glomerulosclerosis. He treated with 
prednisolone, cyclosporin, and 
mycophenolate for six months. There was 
partial remission but no response. He 
received tacrolimus for three months when 
he was ten, but no decreased in 
proteinuria. He had short stature, short 
neck and trunk, kyphoscoliosis, triangular 
face with round tip nose (Figure.1). His 
neurodevelopment was normal and he did 
well at school. His height was 113 cm (< 
3% percentile), weight 22 kg (< 3% 
percentile). He admitted with cough, fever 
and abdominal pain. He was pale and 
lethargic. . In physical exam, blood 
pressure was 115/90, heart rate 90 per 
minute, respiratory distress symptoms and 
coarse crackles in both lungs. Laboratory 
findings were as Table.1. Bone marrow 
aspiration performed and sufficient 
myeloid progenitors were seen, so G-CSF 
prescribed for 5 days and WBC count 
reached to 8,000. On the third day of 
admission, he had fever and respiratory 
distress. There were patchy infiltrates in 
para-cardiac regions in chest X-ray 
(Figure.2). Sonography revealed crossed 
fused ectopia of kidneys right side with 
increased cortical echogenicity.Chest CT-
scan showed upper zone predominance of 
ground glass opacities in both lungs 
(Figure.3). Unfortunately he died of sepsis 
and acute respiratory distress syndrome. 
 
Fig.1: Eleven year old boy with short neck and trunk, triangular face, round tip nose 
andhyperpigmented macules. 
Arad and Pirzadeh 
Int J Pediatr, Vol.6, N.2, Serial No.50, Feb. 2018                                                                                             7153 
 
Fig.2: Chest X-ray revealed patchy infiltrates in paracardiac regions predominantly right side. 
 
Fig.3: Chest CT-scan showed ground glass opacities in both lungs. 
. 
3- DISCUSSION 
     We report a rare case of Schimke 
immune-osseous dysplasia (SIOD) from 
consanguineous parents from North West 
of Iran. Schimke immune osseous 
dysplasia is a multisystem disorder that 
first described by Schimke et al.                   
as chondroitin-6-sulfate 
mucopolysaccharidosis with defective 
cellular immunity and nephrotic syndrome 
(1). Saraiva et al. reported 25 new cases in 
1999(2) and Boerkoel et al. reported 14 
cases in 2000(3), and detected mutant 
chromatin remodeling protein 
SMARCAL1 in 2002(4). Chewing 
proposed SMARCAL1 protein regulates 
proliferation of chondrocytes, 
lymphocytes, spermatozoa and 
maintenance of cardiocytes (5). Basiratnia 
and fallahzadeh reported two cases in 
South of Iran in 2007 (6). They also 
reported an 8 years old boy with SIOD and 
non-Hodgkin lymphoma (7). 
The mutations SMARCAL1 (SWI/ SNF1-
related, matrix-associated, actin-dependent 
regulator of chromatin) are responsible for 
SIOD. New mutations of SMARCAL1 are 
revealed recently. Santangelo et al. 
reported in missense change (P. Arg 247 
Pro; Point mutation with alternation of 
arginine 247 residue to proline) and well-
known non-sense mutation (P.Glu 848; 
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Point mutation of glutamine 848 residue) 
as a mild phenotype (8). Barraza-Garcia et 
al. identified a new mutation in a six years 
old SIOD patient with severe symptoms 
who died of nephropathy. The splicing 
alternation (point. [Leu 539-Ile 548 
deletion]), causes 10 amino acids loss in 
HARP-ATPase catalytic domain and the 
RPA-binding domain (HepA-related 
protein-ATPase is a member of the SNF2 
family of ATP-driven molecular motor 
proteins) (9). Lou et al. assess the 
longevity of 38 SIOD patients and the 
cause of death for 22 of them. The patients 
born after 1990 died of infection, bone 
marrow failure, and stroke. None of them 
died primarily of renal failure. The patients 
with longer survival do not manifest 
recurrent infections, bone marrow failure, 
hypothyroidism, and central nervous 
system symptoms. These patients had two 
SMARCAL1 alleles with missense 
mutations, whereas the patients with 
shorter survival had at least one null allele. 
They also report a 20- year- old woman 
with two SMSRCAL1 null alleles and 
severe symptoms of SIOD (10).  
Boerkoelet al. also observed that some 
missense mutations results in retention of 
partial SMARCAL1 function and cause 
milder disease, whereas nonsense, 
frameshift or splicing mutations causes 
severe disease (4). In a cohort study, 
Baradaran-Heravi et al. review five SIOD 
patients that received bone marrow 
transplantation, but only one had 
prolonged recovery. Disorder of DNA 
repair causes of hypersensitivity to 
cytotoxic and genotoxic agents in these 
individuals (11). 
4- CONCLUSION 
   Nephrotic syndrome due to focal 
segmental glomerulosclerosis may be 
accompanied by syndromes. In our 
province (Qazvin) we see autosomal 
recessive disorders more, because of 
consanguineous marriages. Three cases 
were reported from South of Iran, and we 
report the fourth, from North West of Iran. 
Cause of death in three patients was sepsis 
and respiratory distress, so early 
management of sepsis is important in 
SIOD. 
5- ABBREVIATION 
SMSRCAL1: SWI/SNF Related, Matrix 
Associated, Actin Dependent Regulator of 
Chromatin, Subfamily A Like 1, 
CD4/CD8: Cluster of Differentiation 4/ 
Cluster of Differentiation 8, 
G-CSF: Granulocyte-Colony Stimulating 
Factor, 
SWI/ SNF1: SWItch/ Sucrose Non-
Fermentable. 
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